At a glance
- Originator Central Drug Research Institute
- Class Antiparasitics; Quinolines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 28 Sep 2000 Discontinued-I for Malaria in India (Unknown route)
- 28 Sep 1993 Phase-I clinical trials for Malaria in India (Unknown route)